Navigation Links
Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
Date:6/7/2013

NEW YORK, June 7, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Wall Street Reports announced new research reports highlighting Life Technologies Corporation (NASDAQ: LIFE), PerkinElmer, Inc. (NYSE: PKI), PAREXEL International Corporation (NASDAQ: PRXL), Genomic Health, Inc. (NASDAQ: GHDX), and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Life Technologies Corporation Research Report

On May 23, 2013, Life Technologies Corporation (Life Technologies) announced the introduction of GeneArt Strings DNA Fragments, a cost-effective addition to the Company's custom gene synthesis services. GeneArt Strings are custom-ordered double-stranded segments of DNA that can be up to one kilobase (1,000 base pairs) in length. They offer the advantages of synthetic DNA along with quick processing times and five to seven business day delivery. "GeneArt Strings DNA Fragments constitute a cost-effective option for researchers who seek to reduce their work time and do not need to order genes cloned to a vector," said Nathan Wood, General Manager and Vice President of Synthetic Biology for Life Technologies. GeneArt products, including GeneArt Strings DNA Fragments are for research use only and not intended for diagnostic use. The Full Research Report on Life Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available
'/>"/>

SOURCE Wall Street Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Earlier this month, ... in partnership with the U.S. Air Force on the ... results indicated that this type of fuel made from ... will be important to America’s Eco friendly future. In ... a mandate to become independent of foreign oil over ...
(Date:8/28/2014)... 28, 2014 Whitehouse Laboratories is excited ... partnership with PTI Inspection Systems that will ... of the art leak testing method development and validation ... currently available. As part of this agreement, Whitehouse Labs ... Leak Detection Instrument developed and manufactured by PTI. ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics ... in metabolic disorders, announced today that it has filed ... Securities and Exchange Commission (SEC) relating to the proposed ... The number of shares to be offered and the ... determined. Citigroup and Cowen and Company will ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
Breaking Biology Technology:Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2
... and Two Clinical Candidates Featured -, SOUTH ... a privately held company focused on the discovery,and ... four abstracts have been selected for presentation at ... held in San Diego on,April 12-16, 2008., ...
... Mass., Feb. 12 Mersana, a cancer,therapeutics company, announced ... as Chief Scientific Officer., "We are thrilled that ... said,Julie A. Olson, President and CEO at Mersana. "His ... drug systems are an,ideal match for Mersana. In addition ...
... BOSTON, Feb. 11 PAREXEL International,Corporation (Nasdaq: PRXL ... a 2-for-1 split of its Common Stock, which will ... Holders of PAREXEL,s Common Stock will receive one additional ... held on the record date of,February 22, 2008. The ...
Cached Biology Technology:Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 2Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 3Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2PAREXEL International Announces 2-For-1 Stock Split 2PAREXEL International Announces 2-For-1 Stock Split 3
(Date:8/28/2014)... PAUL (August 28, 2014) Researchers at the University ... facioscapulohumeral muscular dystrophy (FSHD) to be used for muscle ... of potential therapies for FSHD. , The research is ... Cell Reports . , There is no treatment for ... most common type of muscular dystrophy. FSHD is an ...
(Date:8/28/2014)... 2014  Privacy Advocate and Senior Staff Attorney at ... joins the lineup of biometric and mobile commerce experts ... Executive Summit in Tampa, Florida ... speakers include Steven Rahman, Director, Technology and Strategy at Samsung, ... The theme of this year,s event is Mobility at ...
(Date:8/28/2014)... WASHINGTON, Aug. 28, 2014A new method for measuring and ... help doctors and researchers better understand how drug abuse ... surgery and tissue engineering, and lead to better treatment ... by a team of researchers from Stony Brook University ... of Health, was published today in The Optical Society,s ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3
... flowers and their pollinators have resulted in a ... pollinators such as bees, flies or butterflies to ... evolved intriguing mechanisms and attractants, of which nectar ... discovered that nectars of flowers pollinated by butterflies ...
... in the human gut adaptively shifts more than a ... host's diet changes from sugar to complex carbohydrates. , ... to survive rapidly changing nutrient conditions but also helps ... complex microbial society, according to researchers at Washington University ...
... novel,vaccine that uses immune cells as factories to produce ... breast cancers, say researchers at,The University of Texas M. ... is a protein often present / surexpressed in ... Breast Cancer Research,on Nov. 29, 2004, showed that the ...
Cached Biology News:Highly adaptable genome in gut bacterium key to intestinal health 2Highly adaptable genome in gut bacterium key to intestinal health 3Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 2Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 3
... different human fetal normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
... delivery of buffer and fixative results ... version. In Vivo Manual Perfusion Fixation ... of buffer and fixative results in ... use and clean--Complete system with everything ...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... plus assay system offers the ... Designed for batch-processing systems, Long ... density microplates such as 384-well ... Convenient storage conditions ( 2 ...
Biology Products: